Estonia - Kiestonia - Ravimiamet

intervet international b.v. - embutramiid+tetrakaiin+mebesooniumjodiid - süstelahus - 200mg+4,4mg+50mg 1ml 50ml 1tk

Estonia - Kiestonia - Ravimiamet

interchemie werken de adelaar eesti aktsiaselts - butafosfaan+tsüanokobalamiin - süstelahus - 100mg+0,05mg 1ml 100ml 1tk; 100mg+0,05mg 1ml 100ml 6tk

Estonia - Kiestonia - Ravimiamet

huvepharma - halofuginoon - suukaudne lahus - 0,5mg 1ml 1000ml 1tk; 0,5mg 1ml 500ml 1tk

Estonia - Kiestonia - Ravimiamet

zoetis belgium - inaktiveeritud rotaviirus+veiste koroonaviirus, inaktiveeritud+escherichia coli, inaktiveeritud - süstesuspensioon - 1annus+1annus+1annus 5ml 25ml 1tk; 1annus+1annus+1annus 5ml 5ml 10tk

Estonia - Kiestonia - Ravimiamet

dopharma research b.v. - tulatromütsiin - süstelahus - 100mg 1ml 100ml 1tk; 100mg 1ml 250ml 1tk

Estonia - Kiestonia - Ravimiamet

labiana life sciences s.a. - naatriumseleniit+tokoferool - süsteemulsioon - 1mg+70mg 1ml 50ml 1tk; 1mg+70mg 1ml 100ml 1tk

Estonia - Kiestonia - Ravimiamet

livisto int'l s.l. - naatriumlevotüroksiin - tablett - 200mcg 100tk; 200mcg 50tk

Estonia - Kiestonia - Ravimiamet

livisto int'l s.l. - naatriumlevotüroksiin - tablett - 400mcg 100tk; 400mcg 250tk; 400mcg 50tk

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

vbi vaccines b.v. - hepatiit b pinnaantigeen - b-hepatiit - vaktsiinid - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.

Estonia - Kiestonia - Ravimiamet

cp-pharma handelsgesellschaft mbh - maropitant - süstelahus - 10mg 1ml 20ml 1tk; 10mg 1ml 10ml 1tk; 10mg 1ml 50ml 1tk; 10mg 1ml 25ml 1tk